Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $21.7B | $35.9B | $41.3B | $26.5B | $28.2B | |
| Revenue Growth (YoY) | 2.3% | 65.22% | 14.98% | -35.67% | 6.12% | |
| Cost of Revenues | $19.3B | $31.2B | $35.8B | $23B | $24.8B | |
| Gross Profit | $2.5B | $4.6B | $5.4B | $3.5B | $3.4B | |
| Gross Profit Margin | 11.29% | 12.93% | 13.19% | 13.19% | 12.04% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.4B | $1.4B | $1.5B | $1.4B | $1.5B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.4B | $1.4B | $1.5B | $1.4B | $1.5B | |
| Operating Income | $1.1B | $3.2B | $3.9B | $2.1B | $1.9B | |
| Net Interest Expenses | $21.3M | $19.7M | $20.9M | $27.8M | $42M | |
| EBT. Incl. Unusual Items | $1.1B | $3.2B | $4B | $2.2B | $1.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $287.7M | $864.1M | $1B | $547.5M | $463.3M | |
| Net Income to Company | $840.6M | $2.4B | $2.9B | $1.6B | $1.4B | |
| Minority Interest in Earnings | $1.1M | $134.5M | $173.8M | $36.7M | $55.6M | |
| Net Income to Common Excl Extra Items | $840.6M | $2.4B | $2.9B | $1.6B | $1.4B | |
| Basic EPS (Cont. Ops) | $1.40 | $3.70 | $4.64 | $2.68 | $2.26 | |
| Diluted EPS (Cont. Ops) | $1.40 | $3.69 | $4.61 | $2.68 | $2.26 | |
| Weighted Average Basic Share | $598M | $600.5M | $597M | $593.1M | $592.4M | |
| Weighted Average Diluted Share | $599.3M | $601.9M | $600.2M | $595.2M | $593.7M | |
| EBITDA | $1.9B | $4B | $4.7B | $2.9B | $2.8B | |
| EBIT | $1.1B | $3.2B | $3.9B | $2.1B | $1.9B | |
| Revenue (Reported) | $21.7B | $35.9B | $41.3B | $26.5B | $28.2B | |
| Operating Income (Reported) | $1.1B | $3.2B | $3.9B | $2.1B | $1.9B | |
| Operating Income (Adjusted) | $1.1B | $3.2B | $3.9B | $2.1B | $1.9B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $9.3B | $10.3B | $6.2B | $7.5B | $7.6B | |
| Revenue Growth (YoY) | 70.61% | 10.54% | -40.33% | 21.64% | 0.86% | |
| Cost of Revenues | $8.1B | $9B | $5.3B | $6.6B | $6.7B | |
| Gross Profit | $1.2B | $1.3B | $812.7M | $900.2M | $808.5M | |
| Gross Profit Margin | 12.91% | 12.69% | 13.2% | 12.02% | 10.71% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $346.3M | $381.7M | $310.1M | $380.9M | $462.3M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $346.3M | $381.7M | $310.1M | $380.9M | $462.3M | |
| Operating Income | $858.2M | $926.8M | $502.5M | $519.4M | $346.1M | |
| Net Interest Expenses | $4.4M | $4.1M | $7.9M | $13.8M | $17.5M | |
| EBT. Incl. Unusual Items | $858.2M | $968.2M | $512.7M | $518.2M | $343.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $230.9M | $257.6M | $151.7M | $129.3M | $88.7M | |
| Net Income to Company | $634.6M | $717.4M | $361.6M | $392.1M | $272.8M | |
| Minority Interest in Earnings | $22.9M | $35.2M | $6.8M | $17.3M | $15M | |
| Net Income to Common Excl Extra Items | $629.5M | $711.7M | $363.3M | $391.3M | $257.4M | |
| Basic EPS (Cont. Ops) | $1.01 | $1.15 | $0.61 | $0.63 | $0.42 | |
| Diluted EPS (Cont. Ops) | $1.01 | $1.13 | $0.60 | $0.63 | $0.42 | |
| Weighted Average Basic Share | $601.7M | $589.9M | $588.2M | $591.2M | $583.7M | |
| Weighted Average Diluted Share | $601.7M | $600M | $594.3M | $593.4M | $583.7M | |
| EBITDA | $1.1B | $1.1B | $722.1M | $757.1M | $632.3M | |
| EBIT | $858.2M | $926.8M | $502.5M | $519.4M | $346.1M | |
| Revenue (Reported) | $9.3B | $10.3B | $6.2B | $7.5B | $7.6B | |
| Operating Income (Reported) | $858.2M | $926.8M | $502.5M | $519.4M | $346.1M | |
| Operating Income (Adjusted) | $858.2M | $926.8M | $502.5M | $519.4M | $346.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $30.1B | $44B | $29.2B | $26.9B | $29.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $26.4B | $38B | $25.4B | $23.7B | $26.4B | |
| Gross Profit | $3.7B | $6B | $3.8B | $3.2B | $3.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.4B | $1.5B | $1.5B | $1.5B | $1.7B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1.4B | $1.5B | $1.5B | $1.5B | $1.7B | |
| Operating Income | $2.4B | $4.5B | $2.4B | $1.7B | $1.7B | |
| Net Interest Expenses | $23.1M | $21.1M | $25.2M | $55.4M | $48.9M | |
| EBT. Incl. Unusual Items | $2.3B | $4.5B | $2.5B | $1.7B | $1.7B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $598.9M | $1.2B | $668.1M | $390.1M | $421.1M | |
| Net Income to Company | $1.7B | $3.3B | $1.8B | $1.4B | $1.3B | |
| Minority Interest in Earnings | $31.7M | $233.7M | $53.6M | $60M | $64.5M | |
| Net Income to Common Excl Extra Items | $1.7B | $3.3B | $1.8B | $1.4B | $1.3B | |
| Basic EPS (Cont. Ops) | $2.79 | $5.17 | $2.97 | $2.20 | $2.03 | |
| Diluted EPS (Cont. Ops) | $2.79 | $5.13 | $2.95 | $2.18 | $2.03 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $3.2B | $5.3B | $3.2B | $2.6B | $2.7B | |
| EBIT | $2.4B | $4.5B | $2.4B | $1.7B | $1.7B | |
| Revenue (Reported) | $30.1B | $44B | $29.2B | $26.9B | $29.7B | |
| Operating Income (Reported) | $2.4B | $4.5B | $2.4B | $1.7B | $1.7B | |
| Operating Income (Adjusted) | $2.4B | $4.5B | $2.4B | $1.7B | $1.7B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $23.9B | $32.2B | $20.1B | $20.5B | $22B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $20.9B | $27.8B | $17.3B | $17.9B | $19.5B | |
| Gross Profit | $3B | $4.4B | $2.8B | $2.5B | $2.5B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1B | $1.1B | $1.1B | $1.2B | $1.3B | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $1B | $1.1B | $1.1B | $1.2B | $1.3B | |
| Operating Income | $2B | $3.3B | $1.7B | $1.4B | $1.2B | |
| Net Interest Expenses | $16.5M | $15.7M | $20M | $47.6M | $44.4M | |
| EBT. Incl. Unusual Items | $2B | $3.3B | $1.8B | $1.4B | $1.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $526.9M | $878.4M | $499.1M | $343.9M | $301.5M | |
| Net Income to Company | $1.5B | $2.4B | $1.3B | $1B | $913.1M | |
| Minority Interest in Earnings | $31.7M | $131.7M | $11.1M | $34.1M | $42.9M | |
| Net Income to Common Excl Extra Items | $1.5B | $2.4B | $1.3B | $1B | $899.6M | |
| Basic EPS (Cont. Ops) | $2.40 | $3.87 | $2.18 | $1.70 | $1.46 | |
| Diluted EPS (Cont. Ops) | $2.39 | $3.84 | $2.17 | $1.69 | $1.46 | |
| Weighted Average Basic Share | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | |
| Weighted Average Diluted Share | $1.8B | $1.8B | $1.8B | $1.8B | $1.8B | |
| EBITDA | $2.6B | $3.9B | $2.4B | $2.1B | $2B | |
| EBIT | $2B | $3.3B | $1.7B | $1.4B | $1.2B | |
| Revenue (Reported) | $23.9B | $32.2B | $20.1B | $20.5B | $22B | |
| Operating Income (Reported) | $2B | $3.3B | $1.7B | $1.4B | $1.2B | |
| Operating Income (Adjusted) | $2B | $3.3B | $1.7B | $1.4B | $1.2B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.9B | $2.5B | $4.1B | $2.4B | $1.3B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $4.2B | $7.8B | $6.3B | $4.6B | $5.1B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $92.8M | $160.2M | $121.1M | $154.5M | $176.6M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $6.8B | $10.6B | $10.8B | $7.5B | $6.9B | |
| Property Plant And Equipment | $2.6B | $2.4B | $2.3B | $2.7B | $3.2B | |
| Long-Term Investments | $13.6M | $34M | $40M | $33.3M | $34.2M | |
| Goodwill | $1.3B | $2.5B | $2.4B | $2.4B | $2.6B | |
| Other Intangibles | $115.6M | $270.2M | $194.1M | $144.1M | $115.1M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $11.1B | $16.1B | $15.9B | $13B | $12.9B | |
| Accounts Payable | $2.1B | $3.3B | $3B | $2.4B | $2.3B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $495.6M | $471.5M | $502.6M | $579.8M | $612M | |
| Other Current Liabilities | $231.2M | $458.4M | $412M | $357.2M | $284.4M | |
| Total Current Liabilities | $6B | $9.1B | $8.4B | $6.2B | $7.1B | |
| Long-Term Debt | $1.8B | $1.4B | $1.3B | $1.6B | $1.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $8.4B | $12.6B | $11.5B | $9.3B | $9.3B | |
| Common Stock | $135.8M | $132.8M | $130.8M | $143.8M | $133.5M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $2.7B | $3.5B | $4.5B | $3.7B | $3.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $6.8M | $7.7M | $7.6M | $7.1M | $2.2M | |
| Total Equity | $2.7B | $3.5B | $4.5B | $3.8B | $3.6B | |
| Total Liabilities and Equity | $11.1B | $16.1B | $15.9B | $13B | $12.9B | |
| Cash and Short Terms | $1.9B | $2.5B | $4.1B | $2.4B | $1.3B | |
| Total Debt | $2.2B | $1.8B | $1.8B | $2.2B | $2.3B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.7B | $3B | $2.2B | $1.1B | $757.9M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $6.5B | $7.2B | $4.5B | $5.4B | $5.8B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $188.7M | $148.3M | $200M | $239.5M | $300.4M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $8.6B | $10.5B | $7.1B | $7B | $7.3B | |
| Property Plant And Equipment | $2.4B | $2.1B | $2.5B | $3.3B | $4.1B | |
| Long-Term Investments | $33.2M | $38.6M | $41.5M | $35.6M | $37.7M | |
| Goodwill | $2.5B | $2.3B | $2.3B | $2.7B | -- | |
| Other Intangibles | $281.4M | $204.1M | $147.6M | $146.2M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $14B | $15.3B | $12.3B | $13.4B | $14.9B | |
| Accounts Payable | $2.7B | $2.9B | $2.2B | $2.6B | $2.5B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $470.9M | $447.1M | $537.7M | $633.6M | -- | |
| Other Current Liabilities | $1.5B | $1.9B | $1.4B | $2.2B | -- | |
| Total Current Liabilities | $7.5B | $8.6B | $6B | $7.6B | $8.3B | |
| Long-Term Debt | $1.6B | $1.2B | $1.5B | $1.8B | $2.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $11B | $11.4B | $8.9B | $9.9B | $12.2B | |
| Common Stock | $129.7M | $122.9M | $132.3M | $143.4M | $152.1M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $7.5M | $8.1M | $7.7M | $8.3M | $41.5M | |
| Total Equity | $3B | $3.9B | $3.4B | $3.5B | $2.7B | |
| Total Liabilities and Equity | $14B | $15.3B | $12.3B | $13.4B | $14.9B | |
| Cash and Short Terms | $1.7B | $3B | $2.2B | $1.1B | $757.9M | |
| Total Debt | $2.1B | $1.7B | $2B | $2.4B | $3.6B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $840.6M | $2.4B | $2.9B | $1.6B | $1.4B | |
| Depreciation & Amoritzation | $778.8M | $801.7M | $805.2M | $862.4M | $935.7M | |
| Stock-Based Compensation | $13.9M | $17.5M | $22M | $25.6M | $25M | |
| Change in Accounts Receivable | -$146M | -$3.4B | $1.2B | $1.7B | -$783.5M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.8B | $2.7B | $4.6B | $1.9B | $1.7B | |
| Capital Expenditures | $198.2M | $223.1M | $258.6M | $345M | $345.2M | |
| Cash Acquisitions | $93.8M | $986.6M | $85.9M | $74.6M | $268M | |
| Cash From Investing | $163M | -$1.2B | -$256.5M | -$336.1M | -$583.6M | |
| Dividends Paid (Ex Special Dividend) | $509.3M | $588.4M | $1.2B | $1.8B | $1.3B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.1M | -$66.7M | -$209.7M | -- | -$2.3M | |
| Repurchase of Common Stock | $39.4M | $64.5M | $676.4M | $796.7M | $57.9M | |
| Other Financing Activities | -- | $407M | -- | -$7.8M | -$37.5M | |
| Cash From Financing | -$1.1B | -$864.1M | -$2.8B | -$3.5B | -$2.1B | |
| Beginning Cash (CF) | $1.9B | $2.5B | $4.1B | $2.4B | $1.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $861.9M | $642M | $1.5B | -$2B | -$983.3M | |
| Ending Cash (CF) | $2.7B | $3.2B | $5.6B | $322.9M | $300.3M | |
| Levered Free Cash Flow | $1.6B | $2.5B | $4.4B | $1.6B | $1.4B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $634.6M | $717.4M | $361.6M | $392.1M | $272.8M | |
| Depreciation & Amoritzation | $199.7M | $193.2M | $217.4M | $239M | $295.5M | |
| Stock-Based Compensation | $13.2M | $6.3M | $6.7M | $7M | $7.8M | |
| Change in Accounts Receivable | -$1B | $76.5M | $229M | -$289.4M | -$158.6M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $816.1M | $1.1B | $463.1M | $559.4M | $556M | |
| Capital Expenditures | $59.3M | $48.1M | $60.8M | $63.6M | $67.8M | |
| Cash Acquisitions | $13.1M | $70.5M | $42M | $59.9M | $190.8M | |
| Cash From Investing | $340M | -$48.1M | -$90.2M | -$118.9M | -$49.5M | |
| Dividends Paid (Ex Special Dividend) | -$697K | -$5.6M | $13.5M | $14.3M | $114.9M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | $522.6K | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | $42.7M | $94.8M | $351.1K | $926.5K | |
| Other Financing Activities | $405.2M | -- | -$7.9M | -$861.5K | -- | |
| Cash From Financing | -$135.3M | -$186.3M | -$453M | -$193.6M | -$309M | |
| Beginning Cash (CF) | $1.7B | $3B | $2.2B | $1.1B | $757.9M | |
| Foreign Exchange Rate Adjustment | $2.2M | -$29.5M | $1.8M | -$23.6M | -$15.4M | |
| Additions / Reductions | $1B | $801.6M | -$78.3M | $223.4M | $182.2M | |
| Ending Cash (CF) | $2.7B | $3.8B | $2.1B | $1.3B | $924.7M | |
| Levered Free Cash Flow | $756.9M | $1B | $402.3M | $495.9M | $488.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.7B | $3.3B | $1.8B | $1.4B | $1.3B | |
| Depreciation & Amoritzation | $808.6M | $804.3M | $841.7M | $921.5M | $1.1B | |
| Stock-Based Compensation | $32M | $6.8M | $24M | $27.3M | $25.5M | |
| Change in Accounts Receivable | -$2.4B | -$1.3B | $2.9B | -$729.8M | -$320.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.3B | $4.3B | $2.8B | $1.7B | $2B | |
| Capital Expenditures | $225.6M | $203.7M | $330.7M | $397.7M | $285.2M | |
| Cash Acquisitions | $993.4M | $81.1M | $41.4M | $278M | $846.8M | |
| Cash From Investing | -$528.6M | -$600.9M | -$301M | -$649.4M | -$895.2M | |
| Dividends Paid (Ex Special Dividend) | $599.6M | $1.2B | $1.8B | $1.4B | $1.3B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | $613.4K | $694.8M | $707.7M | $168.1M | $49.7M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$1.2B | -$2.2B | -$3.5B | -$2.2B | -$1.9B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $572.2M | $1.5B | -$1.1B | -$1.3B | -$845.4M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2.1B | $4.1B | $2.5B | $1.3B | $1.7B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.5B | $2.4B | $1.3B | $1B | $913.1M | |
| Depreciation & Amoritzation | $598.2M | $600.8M | $637.3M | $696.5M | $813.5M | |
| Stock-Based Compensation | $29.7M | $19M | $21M | $22.7M | $22.8M | |
| Change in Accounts Receivable | -$2.2B | -$58M | $1.6B | -$791.9M | -$314.4M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.6B | $3.2B | $1.4B | $1.1B | $1.4B | |
| Capital Expenditures | $162.8M | $143.3M | $215.4M | $268.1M | $202.8M | |
| Cash Acquisitions | $991.9M | $86.4M | $42M | $245.4M | $819.7M | |
| Cash From Investing | -$733.5M | -$144.4M | -$188.9M | -$502.2M | -$804.2M | |
| Dividends Paid (Ex Special Dividend) | $591.6M | $1.3B | $1.8B | $1.3B | $1.2B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | $484.1M | |
| Long-Term Debt Repaid | -$65.4M | -- | -- | -- | -$250.5M | |
| Repurchase of Common Stock | -- | $630.3M | $661.6M | $32.9M | $24M | |
| Other Financing Activities | $405.2M | -- | -$7.9M | -$19.7M | -$15.7M | |
| Cash From Financing | -$1.1B | -$2.4B | -$3.1B | -$1.9B | -$1.7B | |
| Beginning Cash (CF) | $4.4B | $8.7B | $8.8B | $4.1B | $2.5B | |
| Foreign Exchange Rate Adjustment | $20.9M | -$29.5M | -$57.4M | -$1.1M | -$69.6M | |
| Additions / Reductions | -$140.8M | $677.7M | -$2B | -$1.3B | -$1.1B | |
| Ending Cash (CF) | $4.2B | $9.3B | $6.7B | $2.8B | $1.3B | |
| Levered Free Cash Flow | $1.5B | $3.1B | $1.2B | $861.2M | $1.2B | |
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.